DUBLIN, March 20, 2023 /PRNewswire/ -- The "Global Genital Herpes Treatment Market 2022-2032 by Virus Type, Drug Type, Route of Administration, Patient Gender, Distribution Channel, and Region: Trend Forecast and Growth Opportunity" report has been added to  ResearchAndMarkets.com's offering.

Global genital herpes treatment market will reach $5,051.8 million by 2032, growing by 4.7% annually over 2022-2032, driven by the rising prevalence of sexually transmitted diseases, changing socio-cultural openness, increasing awareness about HSV infection and its symptoms, improved access to antiviral medications, and the government supports.

This 168-page report is based on comprehensive research of the entire global genital herpes treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure

• Growth Drivers

• Restraints and Challenges

• Emerging Product Trends & Market Opportunities

• Porter's Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global genital herpes treatment market in every aspect of the classification from perspectives Virus, Drug Type, Route of Administration, Patient Gender, Distribution Channel, and Region.

Based on Virus Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• HSV-1

• HSV-2

Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Acyclovir

• Valacyclovir

• Famciclovir

• Other Drugs

By Route of Administration, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Oral

• Topical

• Injection

By Patient Gender, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Female

• Male

By Distribution Channel, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Retail Pharmacies

• Hospital Pharmacies

• Online Pharmacies

• Drug Stores

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)

• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

• South America (Brazil, Chile, Argentina, Rest of South America)

• MEA (UAE,Saudi Arabia, South Africa and Rest of MEA)

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

3 Segmentation of Global Market by Virus Type

4 Segmentation of Global Market by Drug Type

5 Segmentation of Global Market by Route of Administration

6 Segmentation of Global Market by Patient Gender

7 Segmentation of Global Market by Distribution Channel

8 Segmentation of Global Market by Region

9 Competitive Landscape

Companies Mentioned

• Abbott

• ADLEY FORMULATIONS

• Aurobindo Pharma Ltd.

• Avet Pharmaceuticals Inc.

• Bausch Health Companies

• Centurion Remedies

• Cipla Ltd.

• Eli Lilly & Company

• Finecure Pharmaceuticals

• GlaxoSmithKline Plc

• Glenmark Pharmaceuticals

• Macleods Pharmaceuticals

• Medico Remedies

• Merck & Co., Inc.

• Novartis AG

• Pfizer

• Reddy's Laboratories

• Sanofi SA

• Teva Pharmaceutical Industries Ltd.

• Torrent Pharma

• Viatris Inc.

• Zeelab Pharmacy

• Zydus Pharmaceuticals, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/w2mqfg

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-genital-herpes-treatment-market-2022-2032-sector-to-reach-5-05-billion-by-2032-at-a-4-7-cagr-301776152.html

SOURCE Research and Markets